RecruitingNCT04952870

Perinatal Covid-19 Infection, NO Pathway, and Minipuberty

Exploratory Multicenter Observational Study to Assess the Outcome of Infants With Perinatal SARS-COV-2 Infection and Its Link With the NO Pathway: the Minipuberty Hypothesis


Sponsor

University Hospital, Lille

Enrollment

180 participants

Start Date

Nov 3, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Some evidence exists that SARS-COV-2 may infect pituitary axis, and therefore may alter hypothalamic function. Whether perinatal COVID-19 is associated with alterations in the maturation of the Hypothalamic-Pituitary-Gonadal (HPG) axis, and specifically with its transient activation occurring during infancy, namely minipuberty, is a major concern. Among the various pathogenic features related to COVID-19, altered minipuberty could be a key factor underlying many multimorbidities later in life, suggesting that they could involve a common causative mechanism that occurs within this short and critical period of time following birth. Altered minipuberty together with NO deficiency seem to be key factors underlying many of these multimorbidities, suggesting that they involve a common causative mechanism that occurs within this short and critical period of time following birth


Eligibility

Max Age: 3 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Inhaled NO and routine care for people with neurodevelopmental disorders and newborn, infant, disease. The study is currently recruiting participants at 2 locations. People eligible for this study include up to age 3 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInhaled NO

Newborn or young infants (\< 3 months) receiving inhaled NO as part of their treatment for severe respiratory failure

OTHERroutine care

Patients treated for respiratory failure


Locations(2)

Hop Jeanne de Flandre Chu Lille

Lille, France

Uri-National and Kapodistrian University of Athens

Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04952870


Related Trials